Europe Antacids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Dosage Form (Tablet, Liquid, and Others); Drug Class (Proton Pump Inhibitors, H2 Antagonist, and Acid Neutralizers); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)

Code: TIPRE00021090 | Pages: 148 | Industry: Pharmaceuticals | Date: Apr 2021
Covid

Market Introduction

The class of drugs that neutralize the acid in the stomach are known as antacids. It is used to treat conditions like heartburn, indigestion, acidity and an upset stomach. These drugs are available over the counter and are usually consumed by mouth. They are available in tablets, capsules, liquid and powder form. There are different types of antacid available like aluminium hydroxide, magnesium carbonate, magnesium trisilicate, magnesium hydroxide, calcium carbonate, and sodium bicarbonate.

 


Get more information on this report :



Market Overview and Dynamics

The Europe antacids market is expected to reach US$ 3,396.21 million in 2027 from US$ 2,438.49 million in 2019. The market is estimated to grow with a CAGR of 4.3% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as the rising prevalence of gastrointestinal diseases and the higher incidence of ageing population. However, the market is expected experiencing slow growth during the forecast period owing to the lack of knowledge associated with gastrointestinal diseases.

Key Market Segments

Based on dosage form, the antacids market is segmented into tablet, liquid, and others. Based on drug class, the antacids market is segmented into proton pump inhibitors, H2 antagonist, and acid neutralizers. Based on distribution channel, the antacids market, is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

 

Major Sources and Companies Listed

Some of the major primary and secondary sources for antacids market included in the report are the Spanish National Statistics Office (INE), the International Trade Administration (ITA), and others.

 

Reasons to buy the report

  • To understand the Europe antacids market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for antacids market
  • Efficiently plan M&A and partnership deals in Europe antacids market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form antacids market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe region

 

 

EUROPE ANTACIDS MARKET SEGMENTATION

 

By Dosage Form

  • Tablet
  • Liquid
  • Others

 

By Drug Class

  • Proton Pump Inhibitors
  • H2 Antagonist
  • Acid Neutralizers
    • Magaldrate
    • Sucralfate
    • Others

 

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

 

By Country

  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

 

Company Profiles

  • Bayer AG
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
  • Sun Pharmaceutical Industries Ltd
  • Sanofi
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy's Laboratories
  • Pfizer Inc
  • Reckitt Benckiser Group Plc
  • Procter & Gamble

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentationss

1.3.1        Antacid Market – By Dosage Form

1.3.2        Antacid Market – By Drug Class

1.3.3        Antacid Market – By Distribution Channel

1.3.4        Europe Antacid Market – By Country

2.           Europe Antacid Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Antacid Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Antacid Market- Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Antacid Market - Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Gastrointestinal Diseases

5.1.2        Higher Incidence of Ageing Population

5.2         Market Restraints

5.2.1        Lack of Knowledge Associated with Gastrointestinal Diseases

5.3         Market Opportunities

5.3.1        Increasing Research and Development Activities Regarding Gastric Disorders

5.4         Future Trends

5.4.1        Increasing Growth of the Pharmaceutical Industry

5.5         Impact Analysis

6.           Antacid Market – Europe Analysis

6.1         Europe Antacid Market Revenue Forecasts and Analysis

7.           Europe Antacid Market Analysis and Forecasts to 2027 – By Dosage Form

7.1         Overview

7.2         Antacid Market Revenue Share, by Dosage Form (2019 and 2027)

7.3         Tablet

7.3.1        Overview

7.3.2        Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Liquid

7.4.1        Overview

7.4.2        Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Others

7.5.1        Overview

7.5.2        Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.           Europe Antacid Market Analysis and Forecasts to 2027– By Drug Class

8.1         Overview

8.2         Antacid Market Revenue Share, by Drug Class (2019 and 2027)

8.3         Proton Pump Inhibitors

8.3.1        Overview

8.3.2        Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.4         H? Antagonist

8.4.1        Overview

8.4.2        H? Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Acid Neutralizers

8.5.1        Overview

8.5.2        Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.3        Magaldrate

8.5.3.1          Overview

8.5.3.2          Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.4        Sucralfate

8.5.4.1          Overview

8.5.4.2          Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.5        Others

8.5.5.1          Overview

8.5.5.2          Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.           Europe Antacid Market Analysis and Forecasts to 2027– By Distribution Channel

9.1         Overview

9.2         Antacid Market Share, by Distribution Channel, 2019 and 2027, (%)

9.3         Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.5         Online Pharmacy

9.5.1        Overview

9.5.2        Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

10.        Antacid Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1      Europe: Antacid Market

10.1.1     Overview

10.1.2     Europe: Antacid Market, by Country, 2019 & 2027 (%)

10.1.3     Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.1       Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.2       Germany: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.3.3       Germany: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.3.3.1       Germany: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.3.4       Germany: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.1.4     UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1       UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2       UK: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.4.3       UK: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.4.3.1       UK: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.4.4       UK: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.1.5     France: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.1       France: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.2       France: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.5.3       France: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.5.3.1       France: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.5.4       France: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.1.6     Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.1       Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.2       Spain: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.6.3       Spain: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.6.3.1       Spain: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.6.4       Spain: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.1.7     Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       Italy: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.7.3       Italy: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.7.3.1       Italy: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.7.4       Italy: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.1.8     Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Rest of Europe: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.8.3       Rest of Europe: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.8.3.1       Rest of Europe: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.8.4       Rest of Europe: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

11.        Impact Of COVID-19 Pandemic on Europe Antacid Market

11.1      Europe: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        COMPANY PROFILES

13.1      Bayer AG

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Takeda Pharmaceutical Company Limited

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Sun Pharmaceutical Industries Ltd

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Sanofi

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Boehringer Ingelheim International GmbH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Dr. Reddy's Laboratories

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Pfizer Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     roducts and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Reckitt Benckiser Group Plc

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Procter & Gamble

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Germany Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 2.             Germany Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 3.             Germany Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 4.             Germany Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 5.             UK Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 6.             UK Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 7.             UK Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 8.             UK Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.             France Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 10.          France Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 11.          France Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 12.          France Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          Spain Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 14.          Spain Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 15.          Spain Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 16.          Spain Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 17.          Italy Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 18.          Italy Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 19.          Italy Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 20.          Italy Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 21.          Rest of Europe Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 22.          Rest of Europe Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 23.          Rest of Europe Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 24.          Rest of Europe Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 25.          Organic Developments Done By Companies

Table 26.          Inorganic Developments Done By Companies

Table 27.          Glossary of Terms, Antacid Market

LIST OF FIGURES

Figure 1.           Antacid Market Segmentation

Figure 2.           Europe Antacid Market Overview

Figure 3.           Tablet Segment Held Largest Share of Dosage Form in Antacid Market

Figure 4.           Proton Pump Inhibitors Segment Held Largest Share of Drug Class in Antacid Market

Figure 5.           Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Antacid Market - Europe PEST Analysis

Figure 7.           Antacid Market Impact Analysis of Driver and Restraints

Figure 8.           Europe Antacid Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           Antacid Market Revenue Share, by Dosage Form (2019 and 2027)

Figure 10.        Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Antacid Market Revenue Share, by Drug Class (2019 and 2027)

Figure 14.        Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        H? Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Antacid Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 21.        Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Europe: Antacid Market, by Key Country – Revenue (2019) (USD Million)

Figure 25.        Europe: Antacid Market, by Country, 2019 & 2027 (%)

Figure 26.        Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        France: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        Impact of COVID-19 Pandemic in European Country Markets

Figure 33.        Growth Strategies Done by the Companies in the Market, (%)

  1. Bayer AG
  2. GlaxoSmithKline plc
  3. Takeda Pharmaceutical Company Limited
  4. Sun Pharmaceutical Industries Ltd
  5. Sanofi
  6. Boehringer Ingelheim International GmbH
  7. Dr. Reddy's Laboratories
  8. Pfizer Inc
  9. Reckitt Benckiser Group Plc
  10. Procter & Gamble
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe antacids market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe antacids market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

 

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Related Tags Europe Antacids Market Europe Antacids Market Research Europe Antacids Market Insight Europe Antacids Market Trends Europe Antacids Market Forecast Europe Antacids Market Share Europe Antacids Market 2027 Europe Antacids Market Growth Europe Antacids Industry Sector Europe Antacids PDF Report Europe Antacids Analysis Europe Antacids Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000